The Relationship Between Level of Transforming Growth Factor - β with Pulmonary Fibrosis in Post Pulmonary Tuberculosis in Medan

Tamara Christine, Amira Permatasari Tarigan, Nuryunita Nainggolan, Fotarisman Zaluchu

Abstract


Background: Untreated or undertreated, pulmonary tuberculosis could cause severe complications until death. After treatment, residual lesions might occur. The presence of residual lesions is varied, including: fibrosis, cavity, bronchiectasis and calcification. Transforming growth factor-β (TGF-β) is a cytokine associated with lung inflammation, which plays a role in lung fibrosis. However, only a few studies have assessed the serum level of TGF-β in post-treatment tuberculosis patients. The main objective of this study was to determine the relationship between TGF-β levels and pulmonary fibrosis in patients with pulmonary tuberculosis.
Methods: 51 patients that had undergone anti-tuberculosis treatment were observed, consisting of 31 men, 20 women. Of all patients, there were 26 people with a smoking history, including 25 men and 1 woman. All patients had been recovered, confirmed by clinical state, laboratory and radiology examination. The ELISA test was performed to measure TGF-β level, while chest X-ray was used to evaluate for the occurence of pulmonary fibrosis.
Results: The mean level of TGF-β in patients with lesion (+) was 7628.02 pg/mL (SD: ±4928.38) while the mean level of TGF-β in patients with lesion (-) was 2315.11 pg/mL (SD: ±505.83). Statistical test showed a significant relationship between TGF-β level and fibrosis lesion (P<0.001).
Conclusions: TGF-β level was significantly higher in post-tuberculosis patients with pulmonary fibrosis.

Keywords


TGF-β, post-pulmonary tuberculosis, lung fibrosis

Full Text:

PDF

References


Kementerian Kesehatan Republik Indonesia Direktorat Jenderal Pengendalian Penyakit dan Penyehatan Lingkungan, Pedoman Nasional Pengendalian Tuberkulosis: Indonesia Bebas Tuberkulosis. Jakarta. 2014

WHO, Global Tuberculosis Report. Geneva. 2016.

Tarigan AP, Pandia P, Eyanoer P, Tina D, Pratama R, Fresia A. Obstructive lung disease as a complication in post pulmonary TB. InIOP Conference Series: Earth and Environmental Science. 2018; 125(1):012154.

Tambunan DT, Tarigan AP, Sinaga B, Pandia P, Eyanoer PC. Correlaton of serum tumor necrosis factor-alpha level with pulmonary function in post pulmonary tuberculosis patients. In respirology. 2017; 22:218.

Harada S, Harada Y, Kitara Y, Takamoto M, Ishibashi T, Sininoda A. Tuberculosis sequelae: clinical aspects. 1990; 831-8.

Kim HY, Song KS, Goo JM, Lee JS, Lee KS, Lim TH. Thoracic sequelae and complication of tuberculosis. 2001; 839-60.

Branton, M & Kopp, JB. TGF-β and fibrosis. Editions scientifiques et medicales Elsevier SAS. 1999:1349-65.

Leask A & Abraham. TGF-β signaling and the fibrotic response. The FASEB Journal. 2004; 18(7):816-27.

McCartney-Francis N, et al. TGF-β regulates production of growth factors and TGF-β by human peripheral blood monocytes. 1990:27–35.

Deveci F, Akbulut HH, Turgut T & Muz MH. Changes in serum cytokine levels in active tuberculosis with treatment. 2005:256–62.

Adhanta S, Tekumalla RR, Jaju J, Purad C, Chepuri R, Samyukta R, et al. Screening Tuberculosis Patients for Diabetes in A Tribal Area in South India. International Union Against Tuberculosis and Lung Disease, Health Solution for the Poor in India. 2013; 3(1):44-7.

Chung Kuei-Pin, Chen Jung-Yueh, Lee Chih-Hsin, Wu Huey-Dong, Wang Jann-Yuan, Lee Li-Na,et al. Trends and predictors Changes in Pulmonary Function after treatment for Pulmonry Tuberculosis. Clinical Science. 2011;66(4):549-55.

Manji Mohammed, Shayo Grace, Mamuta Simon, Mpembeni Rose, Jusbani Ahmad, Mugusi Ferdinand. Lung function among patients with pulmonary Tuberculosis in Dar es Salaam- a cross-sectional study. BMC Pulmonary Medicine. 2016;16:58.

Peraturan Menteri Kesehatan Republik Indonesia Nomor 67 Tahun 2016 Tentang Penanggulangan Tuberkulosis. Jakarta. 2016.

Riskesdas. Laporan Riset Kesehatan Dasar Tahun 2013. Kementerian Kesehatan. Jakarta. 2013.

Menon B, Nima G, Dogra V & Jha S. Evaluation of the radiological sequelae after treatment completion in new cases of pulmonary, pleural and mediastinal tuberculosis. Lung India. 2015;32(3):241-5.

Assoian, RK. et al. Expression and secretion of type β transforming growth factor by activated human macrophages. 1987:6020-4.

Blakytny R, et al. Latent TGF-β1 activation by platelets. Journal of Cell Physiology. 2004:67–76.

Fernandez, IE & Eickelberg O. The Impact of TGF-β on Lung Fibrosis, from Targeting to Biomarkers. American Thoracic Society/ 2012;9(3):111-6.

Gerarduzzi C & Battista JA. Myofibroblast repair mechanisms post-inflammatory response: a fibrotic perspective. Springer. 2016.

Martin GEM, Ask K, Gilpin SE, Kolb M, Gauldie J. The transforming growth factor-beta (TGF-β) family and pulmonary fibrosis. Elsevier. 2006;3(1):99-103.

Massague´ J. Receptors for the TGF-β family. 1992:1067–70.

McAnulty RJ, Laurent GJ, Hill M & Chambers R. Escape from Matrix, Multiple Mechanism for Fibroblast Activation in Pulmonary Fibrosis. The American Thoracic Society. 2008;5:311-5.

Shi M, Zhu J, Wang R, Chen X, Mi L, Walz T & Springer TA. Latent TGF-β structure and activation. Springer. 2011;474:343-51.




DOI: https://doi.org/10.36497/jri.v40i1.90

Refbacks

  • There are currently no refbacks.





Jurnal Respirologi Indonesia
pISSN: 0853-7704 - eISSN: 2620-3162
Address: Jalan Cipinang Bunder No. 19, Cipinang, Pulogadung, Jakarta Timur, DKI Jakarta 13240, Indonesia
Phone: +62-21-2247-4845
Email: editor@jurnalrespirologi.org


An official publication by
the Indonesian Society of Respirology (ISR)

Creative Commons License
Creative Commons Attribution-NonCommercial 4.0 International License

Statcounter